[1]路　娜,古吉敏,闵志波.肿瘤间质比在三阴性乳腺癌患者预后评估中的价值[J].新乡医学院学报,2017,34(12):1089-1092.[doi:10.7683/xxyxyxb.2017.12.011]
　LU Na,GU Ji-min,MIN Zhi-bo.Value of tumor-stroma ratio in evaluating the prognosis of patients with triple-negative breast cancer[J].Journal of Xinxiang Medical University,2017,34(12):1089-1092.[doi:10.7683/xxyxyxb.2017.12.011]
点击复制

肿瘤间质比在三阴性乳腺癌患者预后评估中的价值
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年12
页码:
1089-1092
栏目:
临床研究
出版日期:
2017-12-05

文章信息/Info

Title:
Value of tumor-stroma ratio in evaluating the prognosis of patients with triple-negative breast cancer
作者:
路　娜; 古吉敏; 闵志波
（宜宾市第二人民医院病理科，四川　宜宾　644000）
Author(s):
LU Na; GU Ji-min; MIN Zhi-bo
（Department of Pathology，the Second People′s Hospital of Yibin，Yibin 644000，Sichuan Province，China）
关键词:
肿瘤间质比; 三阴性乳腺癌; 预后
Keywords:
tumor-stroma ratio; triple-negative breast cancer; prognosis
分类号:
R737.9
DOI:
10.7683/xxyxyxb.2017.12.011
文献标志码:
A
摘要:
目的　探讨肿瘤间质比（TSR）在三阴性乳腺癌（TNBC）患者预后评估中的价值。方法　选择2010年1月至2014年12月宜宾市第二人民医院收治的TNBC患者87例，采用苏木精-伊红染色法评估TSR，以TSR<50%为间质丰富组，≥50%为间质稀少组。应用COX回归模型分析TNBC患者无瘤生存率和总体生存率的影响因素，采用Kaplan-Meier法进一步分析TSR对TNBC患者无瘤生存率和总体生存率的影响。结果　87例TNBC患者中，TSR≥50%者38例（间质稀少组），TSR<50%者49例（间质丰富组）。87例TNBC患者的5 a无瘤生存率和总体生存率分别为52.9%（46/87）、56.3%（49/87）。单因素COX回归分析显示，肿瘤直径分期、淋巴结转移、肿瘤个数、TSR与TNBC患者的总体生存率和无瘤生存率有显著相关性（P<0.05）。多因素COX回归模型分析显示，肿瘤直径分期、淋巴结转移、肿瘤个数、TSR是TNBC患者总体生存率和无瘤生存率的独立危险因素（P<0.05）。Kaplan-Meier生存分析显示，间质稀少组TNBC患者的5 a无瘤生存率和总体生存率分别为68.4%（26/38）、73.7%（28/38），间质丰富组TNBC患者的5 a无瘤生存率和总体生存率分别为40.8%（20/49）、42.9%（21/49）。Log-Rank检验显示，间质稀少组TNBC患者总体生存率和无瘤生存率显著高于间质丰富组（χ2=7.788、9.799，P<0.05）。结论　TSR与TNBC患者预后有显著相关，是TNBC患者预后的独立危险因素，可作为TNBC患者评估预后的一项指标。
Abstract:
Objective　To investigate the value of tumor-stroma ratio（TSR） in evaluating the prognosis of patients with triple-negative breast cancer （TNBC）.Methods　A total of 87 patients with TNBC were selected from January 2010 to December 2014 in the Second People′s Hospital of Yibin.The TSR was detected by Hematoxylin eosin staining，the patients with TSR<50% were included in the stroma-rich group，and the patients with TSR≥50% were included in the stroma-rare group.The influencing factors of tumor-free survival and overall survival in TNBC patients were analyzed by COX regression model.The effect of TSR on tumor-free survival and overall survival in TNBC patients was further analyzed by Kaplan-Meier method.Results　Among the 87 TNBC patients，there were 38 patients with TSR≥50% （stroma-rare group） and 49 patients with TSR<50% （stroma-rich group）.The 5-year tumor-free survival rate and overall survival rate of the 87 TNBC patients was 52.9% （46/87） and 56.3% （49/87） respectively.Single factor COX regression analysis showed that the tumor diameter staging，lymph node metastasis，the number of tumors and TSR were significantly correlated with the overall survival rate and tumor-free survival rate of patients with TNBC（P<0.05）.Multivariate COX regression analysis showed that the tumor diameter staging，lymph node metastasis，the number of tumors and TSR were independent risk factors for overall survival rate and tumor-free survival rate of patients with TNBC （P<0.05）.Kaplan-Meier survival analysis showed that the tumor-free survival rate and the overall survival rate of TNBC patients in the stroma-rare group were 68.4% （26/38） and 73.7% （28/38），and they were 40.8% （20/49） and 42.9% （21/49） in the stroma-rich group.The Log-Rank test showed that the overall survival rate and disease-free survival rate of the TNBC patients in the stroma-rare group were significantly higher than those in the stroma-rich group （χ2=7.788，9.799；P<0.05）.Conclusion　TSR is significantly associated with the prognosis of TNBC patients，and it is an independent risk factor for the prognosis of TNBC patients.TSR can be used as an indicator for evaluating the prognosis of TNBC patients.

参考文献/References:

［1］　LV Z，CAI X，WENG X，et al.Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation［J］.Surgery，2015，158（1）：142-150.
［2］　HUIJBERS A，TOLLENAAR R A，PELT G W，et al.The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients：validation in the VICTOR trial［J］.Ann Oncol，2013，24（1）：179-185.
［3］　WEIGELT B，BAEHNER F L，REIS-FILHO J S.The contribution of gene expression profiling to breast cancer classification，prognostication and prediction：a retrospective of the last decade［J］.J Pathol，2010，220（2）：263-280.
［4］　王云生，张清媛.三阴型乳腺癌靶向治疗研究进展［J］.新乡医学院学报，2016，33（9）：815-818.
［5］　WANG K，MA W，WANG J，et al.Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma［J］.J Thorac Oncol，2012，7（9）：1457-1461.
［6］　JING L，JUAN L，JINSONG L，et al.Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma［J］.Gynecol Oncol，2014，132（1）：81-86.
［7］　DEKKER T J，VAN C J，VAN PELT G W，et al.Prognostic significance of the tumor-stroma ratio：validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy （POP） trial （10854）［J］.Breast Cancer Res Treat，2013，139（2）：371-379.
［8］　张保宁，张慧明.三阴性乳腺癌研究进展：第31届圣·安东尼奥乳腺癌研讨会报道［J/CD］.中华乳腺病杂志：电子版，2009，3（1）：5-8.
［9］　KALLURI R，ZEISBERG M.Fibroblasts in cancer［J］.Nat Rev Cancer，2006，6（5）：392-402.
［10］　EREZ N，TRUITT M，OLSON P，et al.Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner［J］.Cancer Cell，2010，17（2）：135-147.
［11］　BHOWMICK N A，NEILSON E G，MOSES H L.Stromal fibroblasts in cancer initiation and progression［J］.Nature，2004，432（7015）：332-337.
［12］　CALON A，TAURIELLO D V，BATLLE E.TGF-beta in CAF-mediated tumor growth and metastasis［J］.Semin Cancer Biol，2014，25（2）：15-22.

相似文献/References:

[1]刘　明,郭　满,张　浩,等.血管生成拟态及骨桥蛋白和基质金属蛋白酶2在三阴性乳腺癌组织中的表达及意义[J].新乡医学院学报,2019,36(4):345.[doi:10.7683/xxyxyxb.2019.04.011]
　LIU Ming,GUO Man,ZHANG Hao,et al.Expression and significance of vasculogenic mimicry，osteopontin and matrix metalloproteinase-2 in triple-negative breast cancer[J].Journal of Xinxiang Medical University,2019,36(12):345.[doi:10.7683/xxyxyxb.2019.04.011]
[2]郭　满,翟晓建,张　浩,等.p38蛋白激酶信号通路对骨桥蛋白介导的三阴性乳腺癌细胞自噬、凋亡活性的影响[J].新乡医学院学报,2018,35(12):1058.[doi:10.7683/xxyxyxb.2018.12.004]
　GUO Man,ZHAI Xiao-jian,ZHANG Hao,et al.Effect of p38 mitogen-activated protein kinase signaling pathway on autophagy and apoptosis activity of triple negative breast cancer cell mediated by osteopontin[J].Journal of Xinxiang Medical University,2018,35(12):1058.[doi:10.7683/xxyxyxb.2018.12.004]
[3]刘德总,杨颖涛.乳腺癌辅助治疗现状与展望[J].新乡医学院学报,2021,38(8):781.[doi:10.7683/xxyxyxb.2021.08.017]
[4]郭彬彬,郭　满,刘　明,等.扭曲蛋白、波形蛋白、血管生成拟态在三阴性乳腺癌组织中的表达及临床意义[J].新乡医学院学报,2021,38(5):436.[doi:10.7683/xxyxyxb.2021.05.008]
　GUO Binbin,GUO Man,LIU Ming,et al.Expression of Twist,vimentin and vasculogenic mimicry in triple-negative breast cancer tissues and its clinical significance[J].Journal of Xinxiang Medical University,2021,38(12):436.[doi:10.7683/xxyxyxb.2021.05.008]
[5]付朝红,刘丹娜,段方方,等.晚期三阴性乳腺癌核苷酸切除修复交叉互补基因1表达与化学治疗效果的关系[J].新乡医学院学报,2017,34(10):904.[doi:10.7683/xxyxyxb.2017.10.010]
　FU Chao-hong,LIU Dan-na,DUAN Fang-fang,et al.Relationship between excision repair cross complementing gene 1 expression and chemotherapeutic efficacy in patients with advanced triple-negative breast cancer[J].Journal of Xinxiang Medical University,2017,34(12):904.[doi:10.7683/xxyxyxb.2017.10.010]
[6]朱方园,邵营波,陈　琦,等.长链非编码RNA前列腺癌相关转录本7对三阴性乳腺癌MDA-MB-436细胞增殖、迁移及侵袭的影响[J].新乡医学院学报,2022,39(8):701.[doi:10.7683/xxyxyxb.2022.08.001]
　ZHU Fangyuan,SHAO Yingbo,CHEN Qi,et al.Effect of long non-coding RNA prostate cancer associated transcript 7 on proliferation,migration and invasion of triple-negative breast cancer MDA-MB-436 cells[J].Journal of Xinxiang Medical University,2022,39(12):701.[doi:10.7683/xxyxyxb.2022.08.001]

更新日期/Last Update: 2017-12-05